The SNMMI practice guideline for therapy of thyroid disease with 131I 3.0.

MLA

Silberstein, Edward B., et al. “The SNMMI Practice Guideline for Therapy of Thyroid Disease with 131I 3.0.” Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine, vol. 53, no. 10, Oct. 2012, pp. 1633–51. EBSCOhost, https://doi.org/10.2967/jnumed.112.105148.

APA

Silberstein, E. B., Alavi, A., Balon, H. R., Clarke, S. E. M., Divgi, C., Gelfand, M. J., Goldsmith, S. J., Jadvar, H., Marcus, C. S., Martin, W. H., Parker, J. A., Royal, H. D., Sarkar, S. D., Stabin, M., & Waxman, A. D. (2012). The SNMMI practice guideline for therapy of thyroid disease with 131I 3.0. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine, 53(10), 1633–1651. https://doi.org/10.2967/jnumed.112.105148

Chicago

Silberstein, Edward B, Abass Alavi, Helena R Balon, Susan E M Clarke, Chaitanya Divgi, Michael J Gelfand, Stanley J Goldsmith, et al. 2012. “The SNMMI Practice Guideline for Therapy of Thyroid Disease with 131I 3.0.” Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine 53 (10): 1633–51. doi:10.2967/jnumed.112.105148.